Straumann Holding AG Revenue 2012-2021 | SAUHY

Straumann Holding AG annual/quarterly revenue history and growth rate from 2012 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Straumann Holding AG revenue for the quarter ending December 31, 2021 was $M, a NAN% increase year-over-year.
  • Straumann Holding AG revenue for the twelve months ending December 31, 2021 was $0M, a NAN% increase year-over-year.
  • Straumann Holding AG annual revenue for 2021 was $2.212B, a 45.46% increase from 2020.
  • Straumann Holding AG annual revenue for 2020 was $1.521B, a 5.34% decline from 2019.
  • Straumann Holding AG annual revenue for 2019 was $1.607B, a 15.24% increase from 2018.
Straumann Holding AG Annual Revenue
(Millions of US $)
2021 $2,212
2020 $1,521
2019 $1,607
2018 $1,394
2017 $1,130
2016 $932
2015 $831
2014 $777
2013 $734
2012 $732
2011 $785
Straumann Holding AG Quarterly Revenue
(Millions of US $)
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2018-12-31
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2014-12-31
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.706B $2.685B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $74.181B 20.24
Becton Dickinson (BDX) United States $68.999B 18.08
Cardinal Health (CAH) United States $31.159B 16.90
West Pharmaceutical Services (WST) United States $25.194B 51.46
Labcorp (LH) United States $20.278B 16.81
Cooper (COO) United States $18.996B 25.72
Align Technology (ALGN) United States $17.330B 33.16
Henry Schein (HSIC) United States $9.324B 17.76
Merit Medical Systems (MMSI) United States $6.104B 31.17
DENTSPLY SIRONA (XRAY) United States $3.848B 10.47
Patterson (PDCO) United States $2.731B 14.59
CONMED (CNMD) United States $2.193B 18.30
STAAR Surgical (STAA) United States $1.137B 41.96
Lifevantage (LFVN) United States $0.298B 39.63
Pro-Dex (PDEX) United States $0.136B 27.05